Cutler Group LP Forte Biosciences, Inc. Call Options Transaction History

Cutler Group LP

$307 Million
Q1 2024

Call Options

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form
Q1 2022 Apr 14, 2022	SELL	$1.21 - $2.24 $16,819 - $31,136	-13,900 Reduced 95.86%	600 $0
Q4 2021 Jan 18, 2022	SELL	$2.02 - $3.36 $31,714 - $52,752	-15,700 Reduced 51.99%	14,500 $0
Q3 2021 Oct 26, 2021	BUY	$2.96 - $36.67 $89,392 - $1.11 Million	30,200 New	30,200 $4,000

Others Institutions Holding FBRX

# of Institutions

1

Shares Held

175K

Call Options Held

0

Put Options Held

0

Black Rock Inc. New York, NY

175K
Shares

$977,456
0.0% of portfolio

About Forte Biosciences, Inc.

Ticker FBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,340,300
Market Cap $114M
Description
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.

More about FBRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.